SubHero Banner
Text

Lyrica® (pregabalin) – Expanded indication

May 23, 2019 - The FDA approved Pfizer’s Lyrica (pregabalin) capsules and oral solution as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.

Download PDF